-       Report 
   - December 2023
    -  35 Pages 
    France
   
   From       €3591EUR$3,995USD£3,149GBP 
                -       Report 
   - December 2023
    -  35 Pages 
    United Kingdom
   
   From       €3591EUR$3,995USD£3,149GBP 
                -       Report 
   - December 2023
    -  31 Pages 
    United States
   
   From       €3591EUR$3,995USD£3,149GBP 
                -       Report 
   - November 2023
    -  32 Pages 
    China
   
   From       €2692EUR$2,995USD£2,361GBP 
                -       Report 
   - November 2023
    -  31 Pages 
    Russia
   
   From       €2692EUR$2,995USD£2,361GBP 
                 -       Report 
   - November 2023
    -  31 Pages 
    Brazil
   
   From       €2692EUR$2,995USD£2,361GBP 
                -       Report 
   - November 2023
    -  21 Pages 
    Brazil
   
   From       €2692EUR$2,995USD£2,361GBP 
                -       Report 
   - November 2023
    -  19 Pages 
    Mexico
   
   From       €2692EUR$2,995USD£2,361GBP 
                From       €116EUR$129USD£102GBP 
                -       Report 
   - May 2025
    -  45 Pages 
    United States
   
   From       €917EUR$1,020USD£804GBP 
                                 
         Glaucoma is a group of eye diseases that damage the optic nerve, leading to vision loss. It is the leading cause of irreversible blindness worldwide. The glaucoma market within the optical industry is focused on providing treatments and technologies to diagnose and manage the disease. This includes medications, laser treatments, and surgical procedures. Additionally, the market includes devices such as tonometers, optical coherence tomography (OCT) systems, and visual field analyzers. These devices    are used to measure intraocular pressure, detect structural changes in the eye, and assess the extent of vision loss.
Companies in the glaucoma market include Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Glaukos, Hoya, Nidek, Topcon, and Ziemer Ophthalmic Systems. Show Less   Read more